This advertisement is brought to you by Talis.

Talis's industry-leading platforms protect critical applications, data and identities,

anywhere at scale with the highest ROI.

That's why the most trusted companies in the world rely on Talis to protect what matters most.

Learn more at talisgroup.com slash cyber.

Here's your morning brief for Thursday, October 9th. I'm Kate Bullivant for the Wall Street Journal.

Israel and Hamas have agreed to a deal that would see all of the remaining

Israeli hostages held in the Gaza Strip released. The deal, which is the first phase of Trump's

plan to end the war, also includes the opening of a border crossing to allow humanitarian aid

into the enclave, the release of Palestinians held in Israeli prisons, and the withdrawal

of Israeli troops in Gaza to an agreed-upon area, though crucial details are still being hashed out.

A host of other issues still need to be resolved in the next phases of the agreement, including

Gaza's post-war future. China is tightening its control over critical minerals

used in high-tech products like EVs and jet fighters. Some products with rare earth materials

originating from China will require export licenses, as will some goods produced with Chinese

technology. The new rules expand on previous moves by

Beijing that have choked the global supply of rare earths and put them at the centre of trade

negotiations with Washington. And we're exclusively reporting that the Trump administration isn't

planning to impose tariffs on generic drugs from foreign countries.

Generic drugs make up about 90% of medicines dispense to Americans every day and a largely

source from abroad. The move follows internal debate over how to bring manufacturing of generic

drugs back to the US and what role tariffs should play in that effort.

...